Correction to: Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma
Crossref DOI link: https://doi.org/10.1007/s10198-019-01137-z
Published Online: 2019-12-04
Published Print: 2020-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vallejo-Aparicio, Laura Amanda
Molina, Jesús
Ojanguren, Iñigo
Viejo Casas, Ana
Huerta, Alicia
Svedsater, Henrik
Text and Data Mining valid from 2019-12-04
Version of Record valid from 2019-12-04
Article History
First Online: 4 December 2019
Free to read: This content has been made available to all.